851822_App1_online_supp – Supplemental material for Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study
Yazid N. Al Hamarneh
Karissa Johnston
Carlo A. Marra
Ross T. Tsuyuki
10.25384/SAGE.8273666.v1
https://sage.figshare.com/articles/journal_contribution/851822_App1_online_supp_Supplemental_material_for_Pharmacist_prescribing_and_care_improves_cardiovascular_risk_but_is_it_cost-effective_A_cost-effectiveness_analysis_of_the_RxEACH_study/8273666
<p>Supplemental material, 851822_App1_online_supp for Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study by Yazid N. Al Hamarneh, Karissa Johnston, Carlo A. Marra and Ross T. Tsuyuki in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada</p>
2019-06-10 12:00:00
pharmacist intervention
Markov cost-effectiveness model
CV events
30 years
risk assessment equations
R x EACH study Background
CV risk reduction
R x EACH
health outcomes
R x EACH randomized trial
Canadian health care system